Cardiovascular Drugs and Therapy

, Volume 26, Issue 4, pp 359–360 | Cite as

New Challenges Ahead for the Newer Oral Thrombin Inhibitors that Aim at Replacing Warfarin in Clinical Practice—Any Role for Scientific Societies in the Debate?

ISCP PRESIDENT'S LETTER

References

  1. 1.
    Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med. 2009;361:1139–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. New Engl J Med. 2009;361:2342–52.PubMedCrossRefGoogle Scholar
  3. 3.
    Skanes AC, Healy JS, Cairns JA, et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol. 2012;28:125–36.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.St. George’s HospitalUniversity of LondonLondonUK

Personalised recommendations